Immunologic Factors: all 3,292 studies that test it
Page 25 of 33. Open to participants first (386), then studies with results posted, then the rest; newest registration first within each.
- Randomized Trial Comparing Lenalidomide With Low Dose Dexamethasone Versus Lenalidomide in Second Line Multiple MyelomaCompletedNCT01450215Phase 2
- Study in Patients With Primary Breast Diffuse Large B-cell LymphomaCompletedNCT01448096Phase 2
- R-2cda and Prolongation of Therapy With Rituximab Alone in Chronic Lymphocytic Leukaemia and Small Lymphocytic LymphomaTerminatedNCT01446900Phase 2
- Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)Active, not recruitingNCT01446133Phase 2
- Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) PatientsCompletedNCT01440582Phase 1
- Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)Status unknownNCT01439750Phase 1
- Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic SyndromeCompletedNCT01433965Phase 1
- Alefacept in Kidney Transplant RecipientsWithdrawnNCT01433770Not applicable
- Rituximab+mVPDL for CD20(+) Adult Acute Lymphoblastic LeukemiaStatus unknownNCT01429610Phase 2
- Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Refractory or Relapsed Indolent Non-Hodgkin LymphomaCompletedNCT01429025Phase 1
- Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic LeukaemiaStatus unknownNCT01423747Phase 3
- ALL-SCT BFM International- HSCT in Children and Adolescents With ALLStatus unknownNCT01423500Phase 3
- Lenalidomide After Reduced-intensity Allogeneic Stem Cell Transplantation for Relapsed Multiple MyelomaTerminatedNCT01421927Phase 1
- MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell LymphomaWithdrawnNCT01415765Phase 1/2
- Pneumococcal Conjugate Vaccine FollowupCompletedNCT01414504Phase 2
- Immune Globulin Subcutaenous (Human), 20%CompletedNCT01412385Phase 2/3
- A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin LymphomaStatus unknownNCT01412307Phase 1/2
- Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to CorticosteroidsCompletedNCT01408550Phase 3
- Study To Evaluate The Safety And Efficacy Of Lenalidomide For Refractory Cutaneous LupusCompletedNCT01408199Phase 4
- Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary ImmunodeficiencyCompletedNCT01406470Phase 3
- Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLLCompletedNCT01400685Phase 1
- Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular LymphomaCompletedNCT01393756Phase 2
- A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's LymphomaCompletedNCT01392716Phase 2
- A Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Non-Hodgkin's LymphomaCompletedNCT01388959Phase 2
- Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate CancerCompletedNCT01378091Phase 1
- Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast CancerTerminatedNCT01375023Phase 2
- Intensified Rituimab Prephase Before FCR in Untreated B-CLLCompletedNCT01370772Phase 2
- Lenalidomide in Patients With Chronic Myelomonocytic LeukemiaStatus unknownNCT01368757Phase 1/2
- Intravenous Immunoglobulins in Severe and Refractory Solar UrticariaCompletedNCT01360658Phase 2
- Anti-CXCR4 (BMS-936564) Alone and in Combination With Lenalidomide/Dexamethasone or Bortezomib/Dexamethasone in Relapsed/Refractory Multiple MyelomaCompletedNCT01359657Phase 1
- Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic LeukemiaCompletedNCT01358253Phase 4
- Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast CancerCompletedNCT01355393Phase 1/2
- Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid TumorsCompletedNCT01352962Phase 1
- Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT)CompletedNCT01352338Phase 1/2
- Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal TransplantationCompletedNCT01350882Phase 3
- Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar AtaxiaCompletedNCT01350440Phase 2
- Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular CarcinomaTerminatedNCT01348503Phase 1
- Study of 7-valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic SyndromeStatus unknownNCT01346007Phase 4
- A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic AnemiaCompletedNCT01345708Phase 2
- Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via CylexStatus unknownNCT01338103Not applicable
- Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative ColitisCompletedNCT01336465Phase 2
- Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell LymphomaCompletedNCT01334502Phase 1
- GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic ShockTerminatedNCT01315496Phase 3
- BRIEF Bendamustine and Rituximab In Elderly FollicularTerminatedNCT01313611Phase 2
- De Novo Everolimus-based Therapy for Renal Transplantation Using Rituximab InductionTerminatedNCT01312064Phase 4
- Rituximab With or Without Lenalidomide in Treating Patients With Previously Untreated Follicular LymphomaTerminatedNCT01307605Phase 2
- Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin LymphomaStatus unknownNCT01307592Phase 2
- Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)CompletedNCT01306578Not applicable
- Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)CompletedNCT01301820Phase 2
- Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by RituximabCompletedNCT01299857Phase 3
- A Study of Carfilzomib, Lenalidomide, Vorinostat, and Dexamethasone in Relapsed and/or Refractory Multiple MyelomaActive, not recruitingNCT01297764Phase 1/2
- A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With Rituximab in Participants With Relapsed or Refractory B-Cell Non-Hodgkins LymphomaCompletedNCT01290549Phase 1
- Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin LymphomaCompletedNCT01290120Phase 2
- Comparison of Two Dose Regimens of Snake Antivenom for the Treatment of Snake Bites Envenoming in NepalCompletedNCT01284855Phase 2
- Lenalidomide in Kaposi Disease Associated With HIV InfectionTerminatedNCT01282047Phase 2
- TREatment of degeNerative and Neoplastic Diseases With RituximabStatus unknownNCT01277172Phase 2/3
- Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic LeukemiaWithdrawnNCT01271283Phase 2
- Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure PatientsCompletedNCT01270932Phase 2
- Efficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During ChildhoodCompletedNCT01268033Phase 2/3
- Alefacept in Patients With Relapsed/Refractory Aplastic AnemiaTerminatedNCT01267643Phase 1
- Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic TransplantCompletedNCT01264315Phase 2
- Pneumococcal Vaccination of Otitis-prone ChildrenCompletedNCT01263210Not applicable
- Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck CancerCompletedNCT01254617Phase 1
- Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancersCompletedNCT01254578Phase 1
- Vaccine Therapy and Sargramostim in Treating Patients With Malignant GliomaCompletedNCT01250470Phase 1
- Lenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01246622Phase 1
- Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to TreatmentCompletedNCT01246557Phase 1/2
- Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid ArthritisCompletedNCT01244958Phase 3
- Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic SyndromeCompletedNCT01243476Phase 3
- Thymoglobulin Induction in Kidney Transplant RecipientsStatus unknownNCT01239563Phase 3
- A Phase II Study of Oral Panobinostat (LBH589) and Rituximab to Treat Diffuse Large B Cell Lymphoma (DLBCL)CompletedNCT01238692Phase 2
- Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose DexamethasoneCompletedNCT01237249Phase 2
- Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDPTerminatedNCT01225276Phase 2/3
- Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine GliomasCompletedNCT01222754Phase 1
- Determining the Maximum Tolerated Dose of Low Dose Interferon-alpha in Conjunction With Nilotinib in Pretreated Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP)CompletedNCT01220648Phase 1
- Thymoglobulin in Unrelated Hematopoietic Progenitor Cell TransplantationStatus unknownNCT01217723Phase 3
- Rituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL)CompletedNCT01213095Phase 2
- Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)SuspendedNCT01211691Phase 1/2
- A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's LymphomaCompletedNCT01209130Phase 1
- Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins LymphomaCompletedNCT01207921Phase 1
- Frontline Therapy in de Novo Multiple Myeloma Patients Under 65CompletedNCT01206205Phase 2
- Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic SyndromeCompletedNCT01205087Phase 2
- Intravenous Immune Globulin (IVIG) to Prevent Neonatal InfectionCompletedNCT01203345Phase 2/3
- Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian CancerTerminatedNCT01202890Phase 1
- LENA-LMA-5:Lenalidomide in Acute Myeloid Leukemia (AML)TerminatedNCT01198054Phase 4
- Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly DiagnosedCompletedNCT01194791Phase 2
- Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With ASCT in the Initial Myeloma up to 65 YearsCompletedNCT01191060Phase 3
- Rituximab Augmentation Following R-CHOP Induction Chemotherapy in Extremely Elderly Patients With Diffuse Large B Cell LymphomaStatus unknownNCT01181999Phase 2
- Rituximab in Auto-Immune Hemolytic AnemiaCompletedNCT01181154Phase 3
- Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular LymphomaWithdrawnNCT01180569Phase 1/2
- Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal CancerCompletedNCT01176552Phase 2
- A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell LymphomaCompletedNCT01169298Phase 1
- Pomalidomide, Cyclophosphamide and Prednisone (PCP) in Patients With Multiple Myeloma (MM) Relapsed and/or Refractory to LenalidomideCompletedNCT01166113Phase 1/2
- Lenalidomide and Cetuximab in Patients With Advanced Solid TumorsStatus unknownNCT01166035Phase 1/2
- A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant RecipientsTerminatedNCT01163799Phase 1
- Revlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma PatientsCompletedNCT01160107Phase 2
- A Study to Compare the Effectiveness of a Drug That Suppresses the Immune System Called Thymoglobulin® in Preventing the Development of a Disease That Affects the Majority of Heart Transplant Recipients Called Cardiac Allograft Vasculopathy (CAV)WithdrawnNCT01157949Phase 3
- B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue SyndromeTerminatedNCT01156922Phase 2
- B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue SyndromeCompletedNCT01156909Phase 2
- Lenalidomide and Paclitaxel in Advanced Solid TumorsStatus unknownNCT01155505Phase 1